PNC Financial Services Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.3K Sell
2,605
-480
-16% -$17.3K ﹤0.01% 3035
2026
Q1
$109K Buy
3,085
+703
+30% +$28.6K ﹤0.01% 2755
2025
Q4
$96.7K Sell
2,382
-1,257
-35% -$54.7K ﹤0.01% 2825
2025
Q3
$171K Buy
3,639
+1,673
+85% +$86.7K ﹤0.01% 2411
2025
Q2
$102K Sell
1,966
-1,794
-48% -$98.4K ﹤0.01% 2696
2025
Q1
$227K Sell
3,760
-1,442
-28% -$92.9K ﹤0.01% 2098
2024
Q4
$356K Buy
5,202
+120
+2% +$8.36K ﹤0.01% 1788
2024
Q3
$366K Buy
5,082
+1,150
+29% +$81.1K ﹤0.01% 1753
2024
Q2
$273K Sell
3,932
-705
-15% -$51.4K ﹤0.01% 1929
2024
Q1
$371K Sell
4,637
-1,384
-23% -$123K ﹤0.01% 1727
2023
Q4
$659K Sell
6,021
-1,094
-15% -$113K ﹤0.01% 1352
2023
Q3
$718K Buy
7,115
+259
+4% +$29.8K ﹤0.01% 1285
2023
Q2
$932K Sell
6,856
-464
-6% -$56.6K ﹤0.01% 1186
2023
Q1
$760K Sell
7,320
-35
-0.5% -$3.38K ﹤0.01% 1276
2022
Q4
$652K Sell
7,355
-265
-3% -$22K ﹤0.01% 1364
2022
Q3
$611K Sell
7,620
-761
-9% -$71.8K ﹤0.01% 1392
2022
Q2
$804K Buy
8,381
+1,313
+19% +$158K ﹤0.01% 1274
2022
Q1
$1.05M Sell
7,068
-631
-8% -$88.1K ﹤0.01% 1208
2021
Q4
$1.09M Buy
7,699
+1,018
+15% +$144K ﹤0.01% 1210
2021
Q3
$874K Buy
6,681
+141
+2% +$18.4K ﹤0.01% 1262
2021
Q2
$899K Buy
6,540
+276
+4% +$37.8K ﹤0.01% 1247
2021
Q1
$820K Buy
6,264
+373
+6% +$44.9K ﹤0.01% 1258
2020
Q4
$659K Sell
5,891
-87
-1% -$8.24K ﹤0.01% 1319
2020
Q3
$469K Buy
5,978
+1,761
+42% +$144K ﹤0.01% 1400
2020
Q2
$304K Sell
4,217
-302
-7% -$21K ﹤0.01% 1670
2020
Q1
$258K Buy
4,519
+530
+13% +$48.9K ﹤0.01% 1667
2019
Q4
$446K Sell
3,989
-9,788
-71% -$1.04M ﹤0.01% 1547
2019
Q3
$1.32M Sell
13,777
-5,015
-27% -$471K ﹤0.01% 1145
2019
Q2
$1.61M Sell
18,792
-37
-0.2% -$3.04K ﹤0.01% 1096
2019
Q1
$1.57M Sell
18,829
-34
-0.2% -$2.47K ﹤0.01% 1109
2018
Q4
$1.21M Sell
18,863
-812
-4% -$55.6K ﹤0.01% 1178
2018
Q3
$1.56M Buy
19,675
+18,770
+2,074% +$1.45M ﹤0.01% 1157
2018
Q2
$67K Buy
905
+192
+27% +$13.1K ﹤0.01% 2798
2018
Q1
$45K Buy
713
+42
+6% +$2.51K ﹤0.01% 3032
2017
Q4
$34K Buy
671
+185
+38% +$9.63K ﹤0.01% 3140
2017
Q3
$26K Buy
486
+303
+166% +$15.2K ﹤0.01% 3238
2017
Q2
$9K Buy
183
+66
+56% +$3.27K ﹤0.01% 3616
2017
Q1
$5K Buy
+117
New +$5.03K ﹤0.01% 3724
2016
Q3
Sell
-166
Closed -$8K 4022
2016
Q2
$8K Sell
166
-7
-4% -$296 ﹤0.01% 3636
2016
Q1
$7K Buy
173
+6
+4% +$235 ﹤0.01% 3688
2015
Q4
$7K Sell
167
-29
-15% -$1.26K ﹤0.01% 3726
2015
Q3
$9K Buy
196
+29
+17% +$1.59K ﹤0.01% 3706
2015
Q2
$9K Buy
167
+69
+70% +$3.72K ﹤0.01% 3835
2015
Q1
$5K Sell
98
-50
-34% -$2.45K ﹤0.01% 4002
2014
Q4
$6K Sell
148
-1,599
-92% -$67K ﹤0.01% 3488
2014
Q3
$64K Buy
1,747
+60
+4% +$2.38K ﹤0.01% 2576
2014
Q2
$74K Buy
1,687
+1,302
+338% +$59K ﹤0.01% 2419
2014
Q1
$17K Buy
385
+90
+31% +$4.01K ﹤0.01% 2897
2013
Q4
$13K Sell
295
-559
-65% -$21.2K ﹤0.01% 2918
2013
Q3
$29K Buy
854
+205
+32% +$6.69K ﹤0.01% 2695
2013
Q2
$20K Buy
+649
New +$21.1K ﹤0.01% 2738

Other funds holding CNMD

PNC Financial Services Group's CNMD Position: Q2 2026 in Review

PNC Financial Services Group reduced its CONMED (CNMD) stake by 16% in Q2 2026, selling an estimated $17.3K and leaving 2,605 shares worth $85.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

PNC Financial Services Group first reported a position in CNMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.61M in Q2 2019. 104 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • PNC Financial Services Group held 2,605 shares of CONMED worth $85.3K as of Q2 2026.
  • PNC Financial Services Group sold 480 CONMED shares in Q2 2026, an estimated $17.3K.
  • CONMED made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3035 holding.
  • PNC Financial Services Group first reported a position in CONMED in Q2 2013 and has held it in 51 quarters since.
  • PNC Financial Services Group's CONMED position peaked at $1.61M in Q2 2019.
  • 104 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.